2025 Southern Hemisphere Influenza Vaccine
ID: SPE2DP24R0005Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/33a1efa129cf4c1893215a30f4f3380d/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is soliciting proposals for the 2025 Southern Hemisphere Influenza Vaccine. This procurement aims to secure the necessary biological products to support immunization efforts for the upcoming influenza season. The vaccines are critical for public health and military readiness, ensuring that personnel are protected against seasonal influenza strains. Interested vendors can reach out to Rosbert Jones at rosbert.jones@dla.mil or 215-737-2380, or Yu Chen at yu.chen@dla.mil or 215-737-2103 for further details regarding the solicitation process.

    Files
    Title
    Posted
    SF1449_SPE2DP24R0005.PDF
    Similar Opportunities
    Injectable Egg-Free Influenza Vaccine
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support is seeking suppliers for an Injectable Egg-Free Influenza Vaccine for the upcoming 2025-2026 flu season, with an estimated requirement of approximately 280,000 doses. The vaccine must be FDA-approved for individuals aged 18 and older, and the successful contractor will need to ensure that the vaccine is ACIP recommended, with specific delivery schedules outlined for the ordered quantities. This procurement is critical for maintaining public health and readiness, and interested vendors should prepare for the solicitation SPE2DP-24-R-0006, expected to be issued around October 18, 2024, with further details available on the DLA Bid Board System and SAM.gov. For inquiries, contact Yu Chen at yu.chen@dla.mil or call 215-737-2103.
    Injectable Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency Troop Support, is soliciting offers for the procurement of an Injectable Influenza Vaccine under solicitation SPE2DP24R0003 and Amendment 0001. This contract aims to secure a reliable supply of influenza vaccines, which are critical for maintaining the health and readiness of military personnel. Interested vendors should note that the offer due date is set for October 23, 2024, at 3:00 PM local time, and they can reach out to Kevin Weintraub at kevin.weintraub@dla.mil or Yu Chen at yu.chen@dla.mil for further inquiries.
    Flu Vaccine Storage and Rotation - Notice of Intent to Sole Source
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Seqirus USA Inc. for the storage and rotation of influenza vaccine stockpiles. This procurement aims to ensure the availability of pediatric vaccines manufactured by Seqirus USA Inc. in the national stockpile, which is critical for responding to potential disease outbreaks or vaccine shortages. Interested parties may express their interest and capability to fulfill this requirement, with all responses considered by the government within fifteen days of the notice's issuance. Quotations should be submitted via email to the contract specialist at uuu0@cdc.gov by close of business on October 22, 2024.
    Azithromycin Suspension
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Azithromycin Suspension, specifically in 200MG/5ML bottles of 15ML, 22.5ML, and 30ML sizes. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for various healthcare needs within the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be fully competitive and unrestricted. Interested parties should prepare for the solicitation, projected for October 2024, and can contact Kahaun Vicks at 215-737-0652 or Kahaun.Vicks@dla.mil for further inquiries.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Emergency Thermal Blanket – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-55 Emergency Thermal Blanket designed for hypothermia prevention. This initiative aims to solicit information and products for evaluation, focusing on low-weight, low-bulk blankets that help maintain warmth in emergency cold weather conditions and are intended for single patient use. The blankets will be manufactured in compliance with the Trade Agreements Act (TAA) and must be on the Distribution and Pricing Agreement (DAPA) for the DLA Troop Support Medical/Surgical Prime Vendor program. Interested vendors should ensure their accounts are active in the System for Award Management (SAM) and prepare for the QSL Announcement expected to be released around December 12, 2024. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    42--RESPIRATOR OUTFIT
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of 17 units of the NSN 4240013634699 Respirator Outfit. This solicitation is a Total Small Business Set-Aside and aims to acquire essential respiratory protective equipment, which is critical for ensuring the safety and health of personnel in various operational environments. Interested vendors are encouraged to submit their quotes electronically, as hard copies of the solicitation will not be provided, and all submissions must be received within the specified timeframe. For inquiries, potential bidders can contact the DLA at DibbsBSM@dla.mil, and further details can be accessed through the DLA's solicitation portal.
    FMD Vaccine Sources Sought
    Active
    Agriculture, Department Of
    The U.S. Department of Agriculture, specifically the Animal and Plant Health Inspection Service, is conducting a sources-sought notice to identify manufacturers capable of producing, storing, and delivering Foot and Mouth Disease (FMD) vaccines. The USDA aims to enhance its vaccine preparedness by acquiring sufficient quantities of FMD vaccines or vaccine precursors to support response activities in the event of an outbreak, focusing on both inactivated products and novel vaccine platforms. This initiative is critical for safeguarding the U.S. livestock industry from the severe economic and health impacts of FMD, with responses due by 1:00 PM EST on October 25, 2024. Interested parties should submit their capability statements to Amanda Imlach at amanda.imlach@usda.gov and Charmion Harris at charmion.harris@usda.gov.
    Fluconazole - SPE2D221-D-0125-P00012 - Final Option Notice
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), has issued a special notice regarding the contract modification for Fluconazole under contract number SPE2D221-D-0125-P00012. This modification announces the exercise of the final option for the procurement of this pharmaceutical product, which is critical for various medical applications within military healthcare. Interested parties can reach out to the primary contact, Courtney Hunter-Stangler, at Courtney.Hunter-Stangler@dla.mil or by phone at 215-737-6845, or to the secondary contact, Jason Wray, at jason.wray@dla.mil or 215-737-0614, for further details regarding this opportunity.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.